Skip to content

DeepCure vs Empress Therapeutics

DeepCure logo

DeepCure

Reimagining small molecule therapies for immune diseases

28 employees · est. 2018 · Boston, United States

VS
Empress Therapeutics logo

Empress Therapeutics

Medicines from within

18 employees · est. 2022 · Watertown, United States

DeepCure is the older company (2018 vs 2022).

Side-by-Side Comparison

DeepCure Empress Therapeutics
Founded
2018 older 2022
Headquarters
Boston, United States Watertown, United States
Employees
28 18
Industry
AI, Biotechnology, Machine Learning AI, Biotechnology
Funding Stage
Series A Venture round
Total Funding
$64.60M $50.00M
Funding Rounds
5 1
Services
Development of small molecule therapies, Research and development of STAT6 inhibitors, Collaboration with academic and research institutions AI-driven drug discovery, Chemilogics platform utilization, Genetic data analysis, Synthetic biology applications
Target Customers
Pharmaceutical companies, Biotech firms, Healthcare providers, Medical researchers, Patients with immune diseases Pharmaceutical companies, Biotechnology firms, Medical researchers
Taxonomy
Small Molecule TherapiesImmune DiseasesInflammatory DiseasesAI-Driven Drug DiscoveryNovel MoleculesDrug Discovery Platform +9 Drug DevelopmentChemilogics PlatformDNA InsightsOral MedicinesGenetic DataEndogenous Molecules +7
Website
deepcure.com empresstx.com
DeepCure logo

About DeepCure

DeepCure, founded in 2018 and headquartered in the United States, is innovating the landscape of small molecule therapies specifically targeting immune and inflammatory diseases. The company's slogan, "Reimagining small molecule therapies for immune diseases," encapsulates its mission to introduce g...

Empress Therapeutics logo

About Empress Therapeutics

Empress Therapeutics, headquartered in the United States, is a pioneering company in the intersection of AI and Biotechnology. Founded in 2020 by Flagship Pioneering, the company is on a mission to create "Medicines from within". Their innovative Empress Chemilogics(TM) platform uniquely leverages...

Also comparing in this category

Comparing more than these two?

Get DeepCure, Empress Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does DeepCure compare?

A PDF of DeepCure and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

DeepCure was founded in 2018, based in Boston, United States, with 28 employees. DeepCure, founded in 2018 and headquartered in the United States, is innovating the landscape of small molecule therapies specifically targeting immune and inflammatory diseases. The company's slogan,. Empress Therapeutics was founded in 2022, based in Watertown, United States, with 18 employees. Empress Therapeutics, headquartered in the United States, is a pioneering company in the intersection of AI and Biotechnology. Founded in 2020 by Flagship Pioneering, the company is on a mission to cr.
DeepCure has raised $64.60M and Empress Therapeutics $50.00M. Latest stage: DeepCure Series A, Empress Therapeutics Venture round.
Both work in AI and Biotechnology and list unmet medical needs among their focus areas.

Compare DeepCure with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at DeepCure on 15 Jun 2026, and Empress Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout